4//SEC Filing
Nolan Sean P. 4
Accession 0001569926-26-000002
CIK 0001806310other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:45 PM ET
Size
8.4 KB
Accession
0001569926-26-000002
Insider Transaction Report
Form 4
Nolan Sean P.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
[F1]2026-01-12+1,008,000→ 3,086,358 total - Award
Employee Stock Option (right to buy)
[F3]2026-01-12+648,000→ 648,000 totalExercise: $4.86Exp: 2036-01-12→ Common Stock (648,000 underlying)
Holdings
- 1,535,545(indirect: See footnote)
Common Stock
[F2]
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date.
- [F2]The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.
- [F3]25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
Signature
/s/ Kamran Alam, Attorney-in-Fact|2026-01-14
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001569926
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:45 PM ET
- Size
- 8.4 KB